From our in-depth interview on "Stem Cell Therapy China - A Breakthrough for Pulmonary Fibrosis":

This clip focus on "China's Stem Cell Breakthrough Reversing Irreversible Lung Disease"

Full article: https://zurl.co/Nx9UK

Want to stay informed? Follow us for more short insights!

#StemCells #StemCellTherapy #IPF #LungDisease #PulmonaryFibrosis #MedicalTourismChina #ChinaMedicalTourism

Stem cell therapy lowers risk of heart failure after a heart attack

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of developing heart failure years later

New Scientist

A significant breakthrough from a Shanghai-based research team is offering new hope for IPF patients. A recent study published in eBioMedicine demonstrates how autologous stem cell therapy successfully reversed lung damage in clinical trial patients.

This highlights the incredible pace of medical innovation available in China.

Read our full analysis: https://zurl.co/RuQdo

#StemCellTherapy #PulmonaryFibrosis #IPF #MedicalInnovation #China #MedTech #MedicalTourismChina #HealthcareNews

🧬 Stem Cell Therapy Market Report 2025 | Innovations, Growth Drivers & Future Trends

It will grow to $14.6 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%.

Read More @ https://goodprnews.com/global-stem-cell-therapy-market-trends/

#marketresearchreport #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC #StemCellTherapy

Global Stem Cell Therapy Market Set to Achieve $14.6 Billion Milestone with Sustained 12.1% CAGR - Good PR News

What are the recent trends in market size and growth for the stem cell therapy market? The stem cell therapy market size has grown rapidly in recent years. It will grow from $7.86 billion in 2024 to $9.26 billion in 2025 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic

Good PR News - Global Free Press Release Submissions Site

Navigating Stem Cell Therapy in China for Neurological Conditions?

A diagnosis like MS, Parkinson's, or ALS can feel overwhelming. Many are now exploring stem cell therapy in China as a new path forward. But where do you start? 🤔

Our new 2026 Patient's Guide is your first step. We dive deep into the treatments, real costs, and how to stay safe on your medical journey.

Full guide: https://zurl.co/LAwg3

#StemCellTherapy #MedicalTourismChina #ChinaMedicalTourism #MedicalTravel

Adult stem cells are showing exciting potential in restoring vision lost to macular degeneration
https://medicalxpress.com/news/2025-09-adult-stem-cells-therapeutic-vision.html
#StemCellTherapy #VisionRestoration #MacularDegeneration #MedicalResearch
Adult stem cells show therapeutic promise in treating vision loss from macular degeneration

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 and older.

Medical Xpress

Japan’s Pharma Leader Seeking Approval for New Parkinson’s Treatment

Japanese pharma giant Sumitomo Pharma just took a significant step toward rebooting brains ravaged by Parkinson’s disease using stem cells, as reported by Japan Times. Sumitomo has announced that it has filed for Japa…
#Japan #JP #JapanNews #health #life #news #parkinson's #Parkinson'sdisease #stemcelltherapy #stemcelltreatment
https://www.alojapan.com/1341763/japans-pharma-leader-seeking-approval-for-new-parkinsons-treatment/

https://www.alojapan.com/1341763/japans-pharma-leader-seeking-approval-for-new-parkinsons-treatment/ Japan’s Pharma Leader Seeking Approval for New Parkinson’s Treatment #health #Japan #JapanNews #life #news #parkinson's #Parkinson'sDisease #StemCellTherapy #StemCellTreatment Japanese pharma giant Sumitomo Pharma just took a significant step toward rebooting brains ravaged by Parkinson’s disease using stem cells, as reported by Japan Times. Sumitomo has announced that it has filed for Japanese regulatory approval for a potentially groundbrea

Gallant, a San Diego, Calif., startup, announced $18 million in funding for an FDA-approved, ready-to-use stem cell therapy to veterinary medicine. @Techcrunch has more:

https://flip.it/rHxvvY

#Tech #Pets #Animals #StemCellTherapy #Startups

Ready-made stem cell therapies for pets could be coming | TechCrunch

Earlier this week, San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary

TechCrunch